Long-term moderate magnesium-deficient diet shows relationships between blood pressure, inflammation and oxidant stress defense in aging rats

Free Radical Biology and Medicine

Volumn 41, Issue 2, 2006, Pages 277-284

  Blache, Denis ^a,b   Devaux, Sylvie ^c   Joubert, Olivier ^a,b   Loreau, Nadine ^a,b   Schneider, Martina ^a,b   Durand, Philippe ^d   Prost, Michel ^d   Gaume, Vincent ^c   Adrian, Markus ^c   Laurant, Pascal ^c   Berthelot, Alain ^c  

^a INSERM   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c Laboratoire de Physiologie et Pharmacologie   (France)

^d Centre Europé en de Recherches et d'Analyses   (France)

Author keywords

Aging; Blood pressure; Inflammation; Magnesium; Oxidant stress

Indexed keywords

ALBUMIN; FIBRINOGEN; FREE RADICAL; INTERLEUKIN 6; LYSOPHOSPHATIDYLCHOLINE; MAGNESIUM; OXYSTEROL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

AGE DISTRIBUTION; AGED; AGING; ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE PREDISPOSITION; ERYTHROCYTE; FIBRINOGEN BLOOD LEVEL; HEMOLYSIS; HYPERTENSION; INFLAMMATION; LIPID OXIDATION; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; STANDARD; TEST MEAL; VASCULAR DISEASE;

ANIMALS; BLOOD PRESSURE; INFLAMMATION; MAGNESIUM DEFICIENCY; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33745467478     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.04.008     Document Type: Article

References (50)

1. Marin J., and Rodriguez-Martinez M.A. Age-related changes in vascular responses. Exp. Gerontol. 34 (1999) 503-512
2. Safar M. Ageing and its effects on the cardiovascular system. Drugs 39 Suppl. 1 (1990) 1-8
3. Folkow B., and Svanborg A. Physiology of cardiovascular aging. Physiol. Rev. 73 (1993) 725-764
4. Laurent S., Lacolley P., Girerd X., Boutouyrie P., Bezie Y., and Safar M. Arterial stiffening: opposing effects of age- and hypertension-associated structural changes. Can. J Physiol Pharmacol. 74 (1996) 842-849
5. Kawasaki T., Sasayama S., Yagi S., Asakawa T., and Hirai T. Non-invasive assessment of the age related changes in stiffness of major branches of the human arteries. Cardiovasc. Res. 21 (1987) 678-687
6. Saris N.E., Mervaala E., Karppanen H., Khawaja J.A., and Lewenstam A. Magnesium. An update on physiological, clinical and analytical aspects. Clin. Chim. Acta 294 (2000) 1-26
7. Maier J.A. Low magnesium and atherosclerosis: an evidence-based link. Mol. Aspects Med. 24 (2003) 137-146
8. Seelig M. Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations-magnesium and chloride loss in refractory potassium repletion. Am. J. Cardiol. 63 (1989) 4G-21G
9. Laurant P., and Touyz R.M. Physiological and pathophysiological role of magnesium in the cardiovascular system: implications in hypertension. J. Hypertens. 18 (2000) 1177-1191
10. Kh R., Khullar M., Kashyap M., Pandhi P., and Uppal R. Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deoxycorticosterone acetate induced hypertension in rats. J. Hypertens. 18 (2000) 919-926
11. Rayssiguier Y., Gueux E., Bussiere L., Durlach J., and Mazur A. Dietary magnesium affects susceptibility of lipoproteins and tissues to peroxidation in rats. J. Am. Coll. Nutr. 12 (1993) 133-137
12. Ravn H.B., Korsholm T.L., and Falk E. Oral magnesium supplementation induces favorable antiatherogenic changes in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 858-862
13. Malpuech-Brugere C., Nowacki W., Daveau M., Gueux E., Linard C., Rock E., Lebreton J., Mazur A., and Rayssiguier Y. Inflammatory response following acute magnesium deficiency in the rat. Biochim. Biophys. Acta 1501 (2000) 91-98
14. Laurant P., Hayoz D., Brunner H.R., and Berthelot A. Effect of magnesium deficiency on blood pressure and mechanical properties of rat carotid artery. Hypertension 33 (1999) 1105-1110
15. Prost, M. Process for the determination by means of free radicals of the antioxidant properties of a living organism or a potentially aggressive agent. US patent [5,135,850], Aug. 4 1992.
16. Blache D., and Prost M. Free radical attack: biological test for human resistance capability. In: Ponnamperuma C., and Gehrke C.W. (Eds). Proceedings of the IX College Park Colloquium on Chemical Evolution: A Lunar-Based Chemical Analysis Laboratory (LBCAL) (1992), NASA, Washington; 1992, pp82-98. 82-98
17. Girodon F., Blache D., Monget A.L., Lombart M., Brunet-Lecompte P., Arnaud J., Richard M.J., and Galan P. Effect of two year supplementation with low dose antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and on antioxidant defense parameters. J. Am. Coll. Nutr. 16 (1997) 357-365
18. Polette A., and Blache D. Effect of vitamin E on acute iron load-potentiated aggregation, secretion, calcium uptake and thromboxane biosynthesis in rat platelets. Atherosclerosis 96 (1992) 171-179
19. Folch J., Lees M., and Sloane-Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1957) 497-509
20. Rose H.G., and Oklander M. Improved procedure for the extraction of lipids from human erythrocytes. J. Lipid Res. 6 (1965) 428-431
21. Bartlett G.R. Phosphorus assay in column chromatography. J Biol. Chem. 234 (1959) 466-468
22. Blache D., Durand P., Girodon F., Gesquière L., and Loreau N. Determination of sterols, oxysterols and fatty acids of phospholipids in cells and lipoproteins: a one sample method. J. Am. Oil Chem. Soc. 75 (1998) 107-113
23. Schneider M., Verges B., Klein A., Miller E.R., Deckert V., Desrumaux C., Masson D., Gambert P., Brun J.M., Fruchart-Najib J., Blache D., Witztum J.L., and Lagrost L. Alterations in plasma vitamin E distribution in type 2 diabetic patients with elevated plasma phospholipid transfer protein activity. Diabetes 53 (2004) 2633-2639
24. Doumas B.T., Watson W.A., and Biggs H.G. Albumin standards and the measurement of serum albumin with bromcresol green. Clin. Chim. Acta 31 (1971) 87-96
25. McNerlan S.E., Crawford V.L., and Stout R.W. Measurement of fibrinogen in frozen plasma. Thromb. Res. 88 (1997) 481-484
26. Rothbaum D.A., Shaw D.J., Angell C.S., and Shock N.W. Cardiac performance in the unanesthetized senescent male rat. J. Gerontol. 28 (1973) 287-292
27. Laurant P., Adrian M., and Berthelot A. Effect of age on mechanical properties of rat mesenteric small arteries. Can. J. Physiol. Pharmacol. 82 (2004) 269-275
28. Weglicki W.B., Phillips T.M., Freedman A.M., Cassidy M.M., and Dickens B.F. Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol. Cell Biochem. 110 (1992) 169-173
29. Weglicki W.B., Phillips T.M., Mak I.T., Cassidy M.M., Dickens B.F., Stafford R., and Kramer J.H. Cytokines, neuropeptides, and reperfusion injury during magnesium deficiency. Ann. N.Y. Acad. Sci. 723 (1994) 246-257
30. Altura B.M., and Altura B.T. Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis. Cell Mol. Biol. Res. 41 (1995) 347-359
31. Touyz R.M., Pu Q., He G., Chen X., Yao G., Neves M.F., and Viel E. Effects of low dietary magnesium intake on development of hypertension in stroke-prone spontaneously hypertensive rats: role of reactive oxygen species. J Hypertens. 20 (2002) 2221-2232
32. Mahfouz M.M., Zhou Q., and Kummerow F.A. Cholesterol oxides in plasma and lipoproteins of magnesium- deficient rabbits and effects of their lipoproteins on endothelial barrier function. Magnesium Res. 7 (1994) 207-222
33. Leonarduzzi G., Sottero B., and Poli G. Oxidized products of cholesterol: dietary and metabolic origin, and proatherosclerotic effects (review). J. Nutr. Biochem. 13 (2002) 700-710
34. Schroepfer Jr. G.J. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol. Rev. 80 (2000) 361-554
35. Bourdon E., Loreau N., Davignon J., Bernier L., and Blache D. Involvement of oxysterols and lysophosphatidylcholine in the oxidized LDL-induced impairment of serum albumin synthesis in HepG2 cells. Arterioscler. Thomb. Vasc. Biol. 20 (2000) 2643-2650
36. Memon R.A., Staprans I., Noor M., Holleran W.M., Uchida Y., Moser A.H., Feingold K.R., and Grunfeld C. Infection and inflammation induce LDL oxidation in vivo. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1536-1542
37. Van Lente F. Markers of inflammation as predictors in cardiovascular disease. Clin. Chim. Acta 293 (2000) 31-52
38. Bourdon E., and Blache D. The importance of proteins in defense against oxidation. Antiox Redox Signal. 3 (2001) 293-311
39. Goldwasser P., and Feldman J. Association of serum albumin and mortality risk. J. Clin. Epidemiol. 50 (1997) 693-703
40. Luoma P.V., Näyhä S., Sikkilä K., and Hassi J. High serum alpha-tocopherol, albumin, selenium and cholesterol, and low mortality from coronary heart disease in northern Finland. J. Intern. Med. 237 (1995) 49-54
41. Phillips A., Shaper A.G., and Whincup P.H. Association between serum albumin and mortality from cardiovascular disease, cancer and other causes. Lancet 16 (1989) 1434-1436
42. Quinlan G.J., Martin G.S., and Evans T.W. Albumin: biochemical properties and therapeutic potential. Hepatology 41 (2005) 1211-1219
43. Halliwell B. Albumin - An important extracellular antioxidant?. Biochem. Pharmacol. 37 (1988) 569-571
44. Zheng H., Liu J., Liu Y., and Klaassen C.D. Hepatocytes from metallothionein-I and II knock-out mice are sensitive to cadmium and tert-butylhydroperoxide-induced cytotoxicity. Toxicol. Lett. 87 (1996) 139-145
45. Bourdon E., Loreau N., and Blache D. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J. 13 (1999) 233-244
46. Bourdon E., Loreau N., Lagrost L., and Blache D. Differential effects of cysteine and methionine residues in the antioxidant activity of human serum albumin. Free Radic. Res. 39 (2005) 15-20
47. Vuong T.D., Stroes E.S.G., Willekes-Koolschijn N., Rabelink T.J., Koomans H.A., and Joles J.A. Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects. Kidney Int. 55 (1999) 1005-1010
48. Joles J.A., Willekes-Koolschijn N., and Koomans H.A. Hypoalbuminemia causes high blood viscosity by increasing red cell lysophosphatidylcholine. Kidney Int. 52 (1997) 761-770
49. Sakai M., Shichiri M., Hakamata H., and Horiuchi S. Endocytosed lysophosphatidylcholine, through the scavenger receptor, plays an essential role in oxidized low-density lipoprotein-induced macrophage proliferation. Trends Cardiovasc. Med. 8 (1998) 119-124
50. Kugiyama K., Ota Y., Takazoe K., Moriyama Y., Kawano H., Miyao Y., Sakamoto T., Soejima H., Ogawa H., Doi H., Sugiyama S., and Yasue H. Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease. Circulation 100 (1999) 1280-1284